PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptNIH Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
J Am Psychiatr Nurses Assoc. Author manuscript; available in PMC Jul 7, 2009.
Published in final edited form as:
PMCID: PMC2706546
NIHMSID: NIHMS122165
Designing for Dissemination: Development of an Evidence-Based Tobacco Treatment Curriculum for Psychiatry Training Programs
Judith J. Prochaska, PhD, MPH, Sebastien C. Fromont, MD, Karen Suchanek Hudmon, DrPH, RPh, and Janine K. Cataldo, RN, PhD
Judith J. Prochaska, Department of Psychiatry, University of California, San Francisco; JProchaska/at/ucsf.edu;
Psychiatry training programs provide a unique arena for affecting professional norms and increasing access to tobacco cessation services among smokers with mental illness. Psychiatry Rx for Change emphasizes evidence-based patient-oriented tobacco treatments relevant for tobacco users with psychiatric disorders. Following Diffusion of Innovations theory and the RE-AIM framework, the curriculum is being disseminated to psychiatry residency and graduate psychiatric nursing programs in the Western United States with plans to study curriculum adoption, implementation, and maintenance on a broad scale. Psychiatry Rx for Change aims to increase the likelihood that smokers with co-occurring disorders will receive evidence-based cessation treatment.
Keywords: tobacco, nicotine dependence, education, training, dissemination
The prevalence of smoking among persons with mental illness is nearly double that of the general population (41% vs. 23%), with even higher prevalence among the seriously mentally ill and those with additional addictions (Lasser et al., 2000; Rohde, Lewinsohn, Brown, Gau, & Kahler, 2003). The mentally ill, who often smoke heavily, make up 44% to 46% of the U.S. tobacco market (Grant, Hasin, Chou, Stinson, & Dawson, 2004; Lasser et al., 2000).
Rates of tobacco-related heart and lung disease and cancers are higher among individuals with mental illness compared with those of age-matched controls (Carney & Jones, 2006; Lichtermann, Ekelund, Pukkala, Tanskanen, & Lonnqvist, 2001; Ruschena et al., 1998). The U.S. Center for Mental Health Services indicates that persons with serious mental illness are dying 25 years prematurely on average, with tobacco-related chronic diseases being leading causes (Colton & Manderscheid, 2006). Affecting not only quantity but also quality of life, tobacco causes serious health complications and affects psychiatric treatment (Himelhoch et al., 2004; Zevin & Benowitz, 1999).
Recent meta-analyses have documented the effectiveness of physician- and nurse-delivered interventions for smoking cessation (Lancaster & Stead, 2004; Rice & Stead, 2008). Of 81 trials identified with more than 46,000 smokers, however, not one was conducted in a psychiatric setting. Although tobacco dependence is recognized as a deadly health condition worthy of intervention in general medicine, its treatment in psychiatry has been largely ignored (Zarin, Pincus, & Hughes, 1997).
Surveys of psychiatric providers’ practices in the early to late 1990s showed very low rates of identification and treatment of patients’ tobacco use (Himelhoch & Daumit, 2003; Montoya, Herbeck, Svikis, & Pincus, 2005). The 2005 survey of the Association of American Medical Colleges (2007), conducted with 801 psychiatrists, indicated that 62% of psychiatrists routinely ask their patients about tobacco use and advise smokers to quit; however, few regularly assessed readiness to quit (44%); provided cessation materials (13%), nicotine replacement (23%), or other pharmacotherapy (20%); arranged follow-up (14%); or made appropriate cessation referrals (11%). Of note, relative to the other medical specialties surveyed, psychiatrists were the least likely to attend to patients’ tobacco use. In the 2008 survey of the American Psychiatric Nurses Association (APNA, 2008), 85% of respondents reported routinely screening patients for tobacco use, 61% referred patients to tobacco intervention resources, and 29% reported that their organization provided intensive tobacco dependence treatment.
Interviews with psychiatric inpatients and chart reviews of psychiatry residents’ clinical encounters have identified lower rates of attention to patients’ tobacco use (Prochaska, Fromont, & Hall, 2005; Prochaska, Gill, & Hall, 2004). Most (52%) psychiatric inpatients, despite repeated contacts with the system, report never having been encouraged to quit smoking by a mental health provider (Prochaska, Fletcher, Hall, & Hall, 2006). Systematic chart review of 570 outpatient mental health visits that examined a 3-month window of care revealed that in only 3% of cases did psychiatry residents advise smokers to quit; in 5%, patients’ readiness to quit was documented; 9% of smokers were offered assistance; and 5% received follow-up attention to their tobacco use (Prochaska et al., 2008). It is clear that obstacles to active psychiatric treatment of tobacco use and dependence need to be addressed.
A primary barrier to delivering smoking cessation counseling in psychiatric practice may be lack of training. In the Association of American Medical Colleges (2007) survey, psychiatrists identified limited education and training for addressing tobacco use and cessation. A variety of curricula has been developed and a recent systematic review concluded that training health professionals to treat tobacco dependence has measurable effects on professional performance including offering counseling, setting quit dates and follow-up visits, distributing self-help materials, and recommending nicotine replacement (Lancaster, Silagy, & Fowler, 2000). Of the 10 trials identified, however, none was conducted with mental health professionals.
In two separate national surveys, only 50% of psychiatry residency training directors and 51% of graduate psychiatric nursing faculty reported that assessment and treatment of tobacco dependence was a component in their programs’ curriculum (APNA, 2008; Prochaska, Fromont, Louie, Jacobs, & Hall, 2006). Among programs that addressed tobacco, curriculum time was a median duration of 1 hour in psychiatry residency programs and 2 hours or less among 76% of graduate psychiatric nursing programs. Among psychiatry residents surveyed in five Northern California programs, few reported receiving adequate tobacco cessation training in medical school (26%) or residency training (21%), as continuing medical education (3%), or on-the-job training (9%; Prochaska et al., 2005).
Dissemination of an evidence-based curriculum has the potential of dramatically increasing delivery of tobacco cessation treatment to smokers with mental illness. Building on the foundation of the successful Rx for Change curriculum developed by Karen Hudmon and colleagues and disseminated nationally to schools of pharmacy and acute care nursing (Heath et al., 2007; Hudmon et al., 2003), we developed Psychiatry Rx for Change, a tobacco treatment curriculum for psychiatry training programs (Prochaska et al., 2008). A packaged and free-to-use program available online, the curriculum aims to serve as a vehicle for systematic dissemination of the Clinical Practice Guideline for treating tobacco dependence in psychiatric patients. This article describes the process undertaken in developing the curriculum and application of Rogers’s (1995) Diffusion of Innovations theory and Glasgow and colleagues’ (2007) RE-AIM framework in guiding dissemination and evaluation of its adoption and implementation in psychiatry residency and graduate psychiatric nursing programs. The RE-AIM model emphasizes consideration of the program: Reach, Efficacy, Adoption, Implementation, and Maintenance (Glasgow & Emmons, 2007).
Curriculum Development
In developing the curriculum, we applied Kern, Thomas, Howard, and Bass’s (1998) framework for medical education curriculum development. Surveys conducted with psychiatry residents (N = 105) and national residency training directors (N = 114) documented the training needs and informed the curriculum’s educational goals and learning objectives (Prochaska et al., 2005; Prochaska, Fromont, et al., 2006). Nationally, tobacco-related content covered in psychiatry residency programs varied greatly (Prochaska, Fromont, et al., 2006). Programs without tobacco content in their curricula identified lack of faculty expertise as a barrier. Most psychiatry residents (94%) and psychiatry residency training directors (89%) reported interest in a model tobacco curriculum focused on smokers with mental illness; the residency directors reported that they would dedicate, on average, 4 hours of curriculum time to tobacco-related training.
The content of the curriculum derives from numerous meta-analyses and clinical practice guidelines that summarize more than 8,700 articles in the literature (American Psychiatric Association, 2006; Fiore et al., 2008). We created a fully referenced curriculum outline, with didactic and interactive learning strategies. An expert advisory group reviewed the outline, and their feedback was incorporated. We then developed curriculum slides and supporting materials, which were evaluated in a focus group with psychiatry residents and informed by individual interviews with psychiatry residency training faculty (Prochaska et al., 2007). The interviews aimed to delineate effective methods for integrating tobacco treatment strategies within psychiatric training and practice and within different clinical orientations.
Curriculum Description
Psychiatry Rx for Change is constructed as independent, but complementary, modules (see Table 1). Most are considered required, with a total time of 4 hours to implement. A few optional modules are available for training programs able to dedicate more time. The material in all content areas of the curriculum is specific to psychiatry and smokers with mental illness. The training emphasizes evidence-based patient-oriented tobacco treatments relevant for tobacco users with psychiatric disorders, including smokers with depression, schizophrenia, anxiety, and alcohol and illicit drug disorders. The cessation strategies are tailored to smokers at all stages of readiness to quit, are amenable to a variety of treatment orientations (e.g., cognitive behavioral, psychodynamic, medication management) and clinical settings (e.g., outpatient, inpatient, addictions treatment), and are fully supported by rigorous scientific research, heavily referenced with current literature citations. Interactive training components include (a) the opportunity for trainees to handle actual (nonprescription) or placebo (prescription) nicotine replacement products while learning key counseling messages; (b) a clinical practice exercise for trainees to practice addressing tobacco with an actual patient in their caseload; and (c) case-based treatment planning with eight fully developed cases differing in demographics, diagnostic details, and stages of change.
TABLE 1
TABLE 1
The Psychiatry Rx for Change Curriculum Components
Psychiatry Rx for Change materials include an instructor guide, the faculty lecture slides, and trainee resource materials. The resource materials include all teaching slides; ancillary handouts on cessation counseling, strategies for managing nicotine withdrawal, a pharmaceutical product guide, and a booklet for patient tracking of mood and tobacco use; recommended readings; a referral resource list; patient cessation brochures; and stickers for streamlining charting of tobacco cessation interventions.
Curriculum Efficacy Evaluation
We evaluated the 4-hour curriculum with 55 psychiatry residents at three programs in the San Francisco Bay Area (Prochaska et al., 2008). For the initial efficacy evaluation, the curriculum was taught by Drs. Prochaska and Fromont, onsite at each of the training programs with the programs’ training directors making the necessary adjustments to accommodate the teaching time into their curriculum hours. The evaluation was approved by the training programs’ Institutional Review Boards, and residents provided informed consent for use of their responses for research. Assessments indicated significant improvements in psychiatry residents’ tobacco-related knowledge, attitudes, confidence, and behaviors from pre- to posttraining with gains sustained at 3-months follow-up (Prochaska et al., 2008). In addition, systematic chart review (N = 1,204) found significant improvements in residents advising smokers to quit, assessing readiness to quit, assisting with quitting, and arranging follow-up (ps < .05); asking about tobacco use was high at baseline due to inclusion on the intake form. On a scale from 1 (poor) to 6 (outstanding), the average rating was 5.4 (SD = 0.6). All residents (100%) recommended that other psychiatry residency programs would benefit from the tobacco cessation training.
With evidence of efficacy, we received funding from the State of California Tobacco-Related Disease Research Program to study dissemination of the curriculum to psychiatry residency training programs and graduate psychiatric nursing programs in the Western United States. The dissemination study is focused on engaging psychiatry residency and graduate psychiatry nursing faculty to integrate and deliver the curriculum within their own coursework.
Dissemination Theoretical Framework
Development of Psychiatry Rx for Change has been grounded in Rogers’s (1995) Diffusion of Innovations theory and Glasgow and colleagues’ (2007) RE-AIM framework, in that we have carefully considered each of the program characteristics so as to maximize the potential for broad-scale dissemination and adoption. Rogers (1995) described diffusion of innovations as “the process by which an innovation is communicated through certain channels over time among members of a social system” (p. 5). The stages of diffusion include dissemination, adoption, implementation, and institutionalization. The rate of diffusion of an innovation depends on attributes of the innovation and characteristics of the adopter, as well as on channels of communication used to disseminate the innovation and the social system. Below, we consider the elements of Psychiatry Rx for Change that we believe will aid in its successful dissemination, adoption, implementation, and institutionalization.
Dissemination of Psychiatry Rx for Change uses a train-the-trainer model and innovative adherence and performance measures. To ease adoption, training and support materials have been developed. Training will be offered at no cost to participants, in-person in San Francisco in May 2009 and online via the Web site (http://rxforchange.ucsf.edu). Travel support and Continuing Medical Education credit are provided. The curriculum Web site offers further support and consultation, thereby reducing perceived complexity. The modular format is designed to aid program adoption, addressing compatibility with existing training. Well-piloted, the program has demonstrated success with early adopters as detailed above in the description of the efficacy study. The relative advantage of participation in the program is that state-of-the-art teaching materials are provided, thereby reducing the amount of effort individual faculty have to put forth to develop similar lectures.
We have increased visibility of the program through conference presentations, continuing medical education trainings, and scientific articles (Prochaska et al., 2007; Prochaska et al., 2005; Prochaska et al., 2008; Prochaska, Fromont, et al., 2006). At the 2006 meeting of the Association for Academic Psychiatry, the curriculum received a presentation award. We have the support of leaders of the American Association for Directors of Psychiatry Residency Training nationally and within state cau-cuses as well as individual training directors who are assisting with disseminating the program to their colleagues. We also have contacted program directors at graduate psychiatry nursing programs, identifying interest in a model tobacco treatment curriculum. In the language of Diffusion Theory, we anticipate that adoption of the program will be based on an authority decision (i.e., the training director’s), which tends to result in the most rapid rate of adoption. Psychiatry training directors exhibit a high level of interconnectedness in their social system and acceptance of new ideas for teaching. We continue to promote awareness through a variety of communication channels, including journal articles, presentations, professional networking, brochures to other allied health schools, online links to the curriculum Web site, and newsletters distributed to the programs. Given the increased awareness of tobacco use among individuals with mental illness, we believe the timing is perfect for dissemination of the Psychiatry Rx for Change curriculum.
In the language of the RE-AIM model, reach considers the extent of the target population—in our case, future psychiatrists and advanced practice psychiatric nurses and other mental health providers—who will receive the training (Glasgow & Emmons, 2007). Efficacy is the effect of the curriculum on intended outcomes, namely, the tobacco-related knowledge, attitudes, confidence, and behaviors of the residents/students and faculty. Adoption is the participation rate among possible settings and the representativeness of participating settings. Implementation is the extent to which the intervention is delivered as intended. Maintenance is the continuation of the intervention over time. Few health promotion interventions have successfully translated into practice (Glasgow & Emmons, 2007). Table 2 considers Glasgow’s RE-AIM dissemination framework and the ways in which the Psychiatry Rx for Change curriculum addresses traditional barriers to adoption in terms of cost, flexibility, ease of use, minimal requirements for faculty expertise and time demand, customizability, and broad relevance.
TABLE 2
TABLE 2
Consideration of the Psychiatry Rx for Change Curriculum in Relation to Traditional Barriers to Dissemination Identified in the RE-AIM Framework
Analysis Plan
Success of the dissemination effort will be analyzed following Glasgow’s RE-AIM framework, which emphasizes the “3 Rs” of dissemination (Glasgow & Emmons, 2007). The representativeness of the sample will be evaluated as the degree of adoption, quantified as the number of graduate psychiatric nursing and psychiatry residency programs out of the total targeted that adopt the curriculum. The adopting programs will be compared with nonadopting programs on general training program characteristics and faculty perceptions of the curriculum. The degree of adoption also will be compared between disciplines. Although we anticipate a high rate of adoption, lower rates would permit analysis of predictors of adoption. Robustness of the curriculum’s effectiveness on residents’/students’ knowledge, attitudes, confidence, and behaviors will be examined in a variety of psychiatry training programs. Replicability will be evaluated as the degree of program effectiveness on resident and graduate psychiatric nursing student outcomes by degree of curriculum implementation over 2 years’ time. Data collection will begin spring 2009 and continue through spring 2011.
Clinician training in evidence-based patient-oriented cessation treatments relevant for tobacco users with co-occurring psychiatric disorders is needed to improve the health of the patients we serve. There is evidence that advanced practice nursing has significant curricular gaps with tobacco education (Heath & Crowell, 2007). National efforts are needed to initiate widespread changes in graduate nursing curriculum with an emphasis on graduate psychiatric and mental health nursing. The expertise of the advance practice psychiatric and mental health nurse to deliver broad-based care while addressing psychiatric morbidities places them in an important position to treat tobacco use and dependence (Cataldo, 2001).
Psychiatry Rx for Change offers a turnkey solution for programs training future psychiatrists and advanced practice psychiatric nurses. The Psychiatry Rx for Change materials are highly comprehensive, fully referenced, and have demonstrated efficacy (Prochaska et al., 2008). Interested faculty can access the curriculum materials via the program Web site at http://rxforchange.ucsf.edu. The Rx for Change program, as well as the train-the-trainer event, are supported by funding from nonindustry sponsors. The train-the-trainer program will provide the opportunity for faculty to network with colleagues and become part of a large dissemination effort addressing an important public health problem.
Psychiatric treatment encounters with both physicians and advanced practice nurses provide an ideal and untapped opportunity for assisting patients with quitting smoking. Ultimately, we envision that this research will lead to a shared, model tobacco cessation curriculum that can be disseminated nationally to psychiatry training programs (residency, nursing, pharmacy, etc.) and thereby effectively reach this vulnerable and costly population of smokers. More broad, the process by which Psychiatry Rx for Change has been developed and the application of theory to inform the curriculum’s dissemination plan and evaluation also may serve as a useful model for other curriculum areas.
Acknowledgments
This work was supported by the State of California Tobacco-Related Disease Research Program (#13KT-0152 and #17RT-0077) and the National Institute on Drug Abuse (#K23 DA018691 and #P50 DA09253). The authors acknowledge their expert advisory group members Neal Benowitz, MD, Stuart Eisendrath, MD, Sharon Hall, PhD, Mark Myers, PhD, Victor Reus, MD, Steven Schroeder, MD, and Doug Ziedonis, MD, who provided valuable input on identification of the curriculum’s content.
Contributor Information
Judith J. Prochaska, Department of Psychiatry, University of California, San Francisco; JProchaska/at/ucsf.edu.
Sebastien C. Fromont, Department of Psychiatry, University of California, San Francisco, and Alta Bates Summit Medical Center, Berkeley, California; sfromont/at/itsa.ucsf.edu.
Karen Suchanek Hudmon, Purdue University School of Pharmacy & Pharmaceutical Sciences; khudmon/at/purdue.edu.
Janine K. Cataldo, Department of Physiological Nursing–Geriatrics, University of California, San Francisco; janine.cataldo/at/nursing.ucsf.edu.
  • American Psychiatric Association. Practice guideline for the treatment of patients with substance use disorders. 2. Washington, DC: Author; 2006.
  • American Psychiatric Nurses Association. Tobacco dependence survey. 2008. [Retrieved October 10, 2008]. from http://www.apna.org/i4a/pages/index.cfm?pageid=3654.
  • Association of American Medical Colleges. Physician behavior and practice patterns related to smoking cessation, full report. 2007. [Retrieved October 10, 2008]. from http://www.aamc.org/workforce/smoking-cessation-full.pdf.
  • Carney CP, Jones LE. Medical comorbidity in women and men with bipolar disorders: A population-based controlled study. Psychosomatic Medicine. 2006;68:684–691. [PubMed]
  • Cataldo JK. The role of advanced practice psychiatric nurses in treating tobacco use and dependence. Archives of Psychiatric Nursing. 2001;15:107–119. [PubMed]
  • Colton CW, Manderscheid RW. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Preventing Chronic Disease: Public Health Research, Practice and Policy. 2006;3(2):A42. [PMC free article] [PubMed]
  • Fiore MC, Jaén CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, et al. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services; 2008. Treating tobacco use and dependence: 2008 update.
  • Glasgow RE, Emmons KM. How can we increase translation of research into practice? Types of evidence needed. Annual Review of Public Health. 2007;28:413–433. [PubMed]
  • Glasgow RE, Marcus AC, Bull SS, Wilson KM. Disseminating effective cancer screening interventions. Cancer. 2004;101:1239–1250. [PubMed]
  • Grant BF, Hasin DS, Chou SP, Stinson FS, Dawson DA. Nicotine dependence and psychiatric disorders in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry. 2004;61:1107–1115. [PubMed]
  • Heath J, Crowell N. Factors influencing intentions to integrate tobacco education among advanced practice nursing faculty. Journal of Professional Nursing. 2007;23:189–200. [PubMed]
  • Heath J, Kelley FJ, Andrews J, Crowell N, Corelli RL, Hudmon KS. Evaluation of a tobacco cessation curricular intervention among acute care nurse practitioner faculty members. American Journal of Critical Care. 2007;16:284–289. [PubMed]
  • Himelhoch S, Daumit G. To whom do psychiatrists offer smoking-cessation counseling? American Journal of Psychiatry. 2003;160:2228–2230. [PubMed]
  • Himelhoch S, Lehman A, Kreyenbuhl J, Daumit G, Brown C, Dixon L. Prevalence of chronic obstructive pulmonary disease among those with serious mental illness. American Journal of Psychiatry. 2004;161:2317–2319. [PubMed]
  • Hudmon KS, Corelli RL, Chung E, Gundersen B, Kroon LA, Sakamoto LM, et al. Development and implementation of a tobacco cessation training program for students in the health professions. Journal of Cancer Education. 2003;18:142–149. [PubMed]
  • Kern DE, Thomas PA, Howard DM, Bass EB. Curriculum development for medical education: A six step approach. Baltimore: Johns Hopkins University Press; 1998.
  • Lancaster T, Silagy C, Fowler G. Training health professionals in smoking cessation. Cochrane Database of Systematic Reviews. 2000;3:CD000214. [PubMed]
  • Lancaster T, Stead LF. Physician advice for smoking cessation. Cochrane Database of Systematic Reviews. 2004;4:CD000165. [PubMed]
  • Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: A population-based prevalence study. Journal of the American Medical Association. 2000;284:2606–2610. [PubMed]
  • Lichtermann D, Ekelund J, Pukkala E, Tanskanen A, Lonnqvist J. Incidence of cancer among persons with schizophrenia and their relatives. Archives of General Psychiatry. 2001;58:573–578. [PubMed]
  • Montoya ID, Herbeck DM, Svikis DS, Pincus HA. Identification and treatment of patients with nicotine problems in routine clinical psychiatry practice. American Journal of Addictions. 2005;14:441–454. [PMC free article] [PubMed]
  • Prochaska JJ, Fletcher L, Hall SE, Hall SM. Return to smoking following a smoke-free psychiatric hospitalization. American Journal of Addictions. 2006;15:15–22. [PubMed]
  • Prochaska JJ, Fromont SC, Banys P, Eisendrath SJ, Horowitz MJ, Jacobs MH, et al. Addressing nicotine dependence in psychodynamic psychotherapy: Perspectives from residency training. Academic Psychiatry. 2007;31:8–14. [PubMed]
  • Prochaska JJ, Fromont SC, Hall SM. How prepared are psychiatry residents for treating nicotine dependence? Academic Psychiatry. 2005;29:256–261. [PubMed]
  • Prochaska JJ, Fromont SC, Leek D, Hudmon K, Louie AK, Jacobs MH, et al. Evaluation of an evidence-based tobacco treatment curriculum for psychiatry residency training programs. Academic Psychiatry. 2008;32:484–492. [PMC free article] [PubMed]
  • Prochaska JJ, Fromont SC, Louie AK, Jacobs MH, Hall SM. Training in tobacco treatments in psychiatry: A national survey of psychiatry residency training directors. Academic Psychiatry. 2006;30:372–378. [PubMed]
  • Prochaska JJ, Gill P, Hall SM. Treatment of tobacco use in an inpatient psychiatric setting. Psychiatric Services. 2004;55(11):1265–1270. [PubMed]
  • Rice VH, Stead L. Nursing interventions for smoking cessation. Cochrane Database of Systematic Reviews. 2008;4:CD001188. [PubMed]
  • Rogers EM. Diffusion of innovations. 4. New York: Free Press; 1995.
  • Rohde P, Lewinsohn PM, Brown RA, Gau JM, Kahler CW. Psychiatric disorders, familial factors and cigarette smoking: I. Associations with smoking initiation. Nicotine and Tobacco Research. 2003;5:85–98. [PubMed]
  • Ruschena D, Mullen PE, Burgess P, Cordner SM, Barry-Walsh J, Drummer OH, et al. Sudden death in psychiatric patients. British Journal of Psychiatry. 1998;172:331–336. [PubMed]
  • Zarin DA, Pincus HA, Hughes JR. Treating nicotine dependence in mental health settings. Journal of Practical Psychiatry and Behavioral Health. 1997;1:250–254.
  • Zevin S, Benowitz NL. Drug interactions with tobacco smoking. An update. Clinical Pharmacokinetics. 1999;36:425–438. [PubMed]